Status:
COMPLETED
Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites
Lead Sponsor:
Hala Abd EL-Tawab Ibrahim Radwan
Conditions:
Hepatic Ascites
Eligibility:
All Genders
25-65 years
Phase:
PHASE2
Brief Summary
This work aimed to evaluate and compare the impact of adding hypertonic saline solution (HSS) infusion and/or etilefrine to oral diuretics therapy on clinical outcomes, renal and systemic hemodynamics...
Detailed Description
This comparative, randomized, prospective controlled clinical trial was conducted on 90 cirrhotic patients with ascites who were admitted to the Hepatology Department of National Liver Institute, Meno...
Eligibility Criteria
Inclusion
- All cirrhotic patients with ascites grade I- III.
- Patients ages from 25 -65 years.
Exclusion
- Non-cirrhotic ascites.
- Congestive heart failure.
- Acute renal failure.
- Hepatocellular carcinoma.
- All Cancer types.
- Arterial hypertension.
- Acute infection.
Key Trial Info
Start Date :
November 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04785755
Start Date
November 30 2017
End Date
April 30 2020
Last Update
March 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National liver institute- menoufiya university
Shibīn al Kawm, Monufia Governorate, Egypt, 32511